Scientists have proven the effectiveness of a new remedy for psoriasis

Experts have summed the results of Phase III of two clinical trials of the medicinal product tildrakizumab - antibody having a specific purpose. The medicinal product belongs to a class of biological agents that make the body to fight against a disease. The experts consider the results are promising, UPI.com reports.

More than 1,800 patients with moderate and severe chronic psoriasis participated in the Phase III of clinical trials (reSURFACE 1 and reSURFACE 2). At the beginning of the study, the participants had psoriasis on 30% of the body surface area. The volunteers received 200 ml, 100 ml of tildrazizumab or a placebo.

After 12 weeks, the skin became completely or almost completely clean in 65% of the patients. The psoriasis severity has decreased by 75%. In the placebo group, less than 10% of volunteers experienced the same improvement. The participants withstood the drug therapy well. The scientists emphasize that this is not the end. Apparently, the patients’ health will continue to improve.

Source: UPI.com.